ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Amundi Nasdaq100 Ucits Etf Eur

Amundi Nasdaq100 Ucits Etf Eur (ANX)

233.70
-0.40
( -0.17% )
更新日時: 19:32:55

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
233.70
買値
233.65
売値
233.80
出来高
749
233.10 日の範囲 233.75
0.00 52 週間の範囲 0.00
前日終値
234.10
始値
233.25
最終取引時間
19:24:16
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

ANX 最新ニュース

ADVENTRX Announces Management Promotions

SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that, effective immediately, Brian M. Culley, previously the Company's Chief Business...

ADVENTRX Appoints Icahn Representative to Board of Directors

SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that Odysseas D. Kostas, M.D. will join its Board of Directors. Dr. Kostas also will...

ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9

SAN DIEGO, Feb. 2 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the...

ADVENTRX Pharmaceuticals Announces Closing of Financing

SAN DIEGO, Jan. 7 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has completed the previously announced sale of shares of its Series E...

ADVENTRX Pharmaceuticals to Present at the OneMedForum Finance Conference on January 13

SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the...

ADVENTRX Pharmaceuticals Announces Financing

SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has signed agreements to purchase shares of its Series E convertible preferred...

ADVENTRX Pharmaceuticals Submits ANX-530 New Drug Application

SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug...

ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference

SAN DIEGO, Dec. 9 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present to...

ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514

South Korean Partner Demonstrates Bioequivalence and Similar Toxicity Profile to Taxotere SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today...

ADVENTRX Pharmaceuticals Reports Third Quarter Financial Results

SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the three and nine months ended September 30, 2009. "Our third...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AALAmerican Airlines Group Inc
US$ 17.60
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1445
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.60
(0.00%)
0
AACGATA Creativity Global
US$ 0.9791
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.60
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1445
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.60
(0.00%)
0
AACGATA Creativity Global
US$ 0.9791
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.60
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1445
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.60
(0.00%)
0
AACGATA Creativity Global
US$ 0.9791
(0.00%)
0